Application 215126
- Type
- ANDA
- Sponsor
- SUN PHARM INDS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LIFITEGRAST | LIFITEGRAST | SOLUTION/DROPS;OPHTHALMIC | 5% | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xiidra | LIFITEGRAST | Novartis Pharmaceuticals Corporation | 8589d376-ac10-4ddb-9c53-2e0c8d5675c4 | 2025-08-18 | Adverse reactions | LIFITEGRAST |
| Xiidra | LIFITEGRAST | Bausch & Lomb Incorporated | 1a914080-a3c0-44be-b601-0ae3160e77eb | 2024-11-21 | Adverse reactions | LIFITEGRAST |
| Lifitegrast | LIFITEGRAST | Aurobindo Pharma Limited | 1d4b4b61-79da-4b6f-bb19-056d111bf400 | 2023-11-13 | Adverse reactions | Lifitegrast LIFITEGRAST |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 73411 | ORIG | 2023-02-08 |